|
|
June 2008 (Barcelona, Milan, Paris, Rotterdam, Stockholm, London & Berlin)
illumina presentations
Evolution of Illumina’s DNA Analysis Products
Debora Bailey, Illumina
An Overview of Illumina’s Expanding Gene Expression Portfolio
Shawn Baker, Ph.D., Illumina
Illumina’s VeraCode™ Technology From Research to Molecular Diagnostics
Naomi O’Grady, Illumina
customer presentations
Gene Expression Profiling in Celiac Disease
Marcel Bruinenberg, Ph.D., University Medical Centre Groningen
Origins of the Domestic Cat and of the Cat Breeds with VeraCode Technology
Lutz Froenicke, Ph.D., UC Davis
Genome-Wide Methylation and Expression Studies Including miRNA Analysis
Bernard Korn, Ph.D., DKFZ
Pharmacogenetics and Osteoporosis Risk Profile: Implementation of VeraCode Technology into Routine Genetics Laboratory
Pierre-Alain Menoud, Ph.D., Gene Predictis SA
CNV and Aneuploidy Analysis Using QuantiSNP
Jiannis Ragoussis, Ph.D., Wellcome Trust Centre for Human Genetics
Analysis of mRNA Isoform Expressions by Illumina mRNA Sequencing
Rickard Sandberg, Ph.D., Karolinska Institute
March 2008 (Amsterdam, Copenhagen, London & Milan)
illumina presentations
Illumina Genome Analyzer Update
customer presentations
Illumina Genome Analyzer Sequencer Practicalities of Operation at High Throughput
Chris Clee, Ph.D., Welcome Trust Sanger Institute, Cambridge
Detection of Single Nucleotide Polymorphisms and Copy Number Variations
Using the Genome Analyzer
Jakob Hedegaard, Ph.D., University of Aarhus, Denmark
Tag Based Transcriptomics: Transcript Analysis Beyond Microarrays
Kåre Lehmann Nielsen, Ph.D., Ålborg University, Denmark
cDNA and 5’ Tag Sequencing, New Techniques for Obligate Biotroph Pathogens
Eric Kemen, Ph.D., The Sainsbury Laboratory, Norwich
February 2008 (Berlin, Munich & Paris)
illumina presentations
Illumina Genome Analyzer Update
customer presentations
Our Experience with Genome Analyzer Applications: From Sample Preparation to Data Analysis
Laurent Farinelli, Ph.D., Fasteris SA, Switzerland
Re-Sequencing of Large Genomes with the Illumina Genome Analyzer
Stephan Ossowski, Ph.D. and Korbinian Schneeberger, Ph.D., Max Planck Institute, Tubingen
Re-Sequencing of Bacterial Genomes on Genome Analyzer: Case study
Kerstin Stangier, Ph.D., GATC Biotech AG, Germany
November 2007 (Vancouver, Seattle & San Francisco)
illumina presentations
RNA Analysis Solutions from Illumina, Inc.
Tanya Boyaniwsky, Illumina
Introduction to Illumina’s VeraCode™ Technology: Advancing Molecular
Testing to the 21st Century
Mickie Henshall, Illumina
DNA Analysis Solutions from Illumina
Diane Lince, Ph.D., Illumina
customer presentations
Cross-Platform Comparisons of Microarray Data: Implications for the Role of
Annotation
Michael Mooney, Oregon Health Sciences University
Defining the Molecular Mechanisms of TLR Ligand Response Differences Between
Adult and Neonatal Dendritic Cells
Edgardo S. Fortuno III, University of Washington
High-Resolution Genome-Wide Mapping of Protein: DNA Interactions Using
Solexa® Sequencing
David Johnson, Ph.D., Stanford
September 2007 (St. Louis & Philadelphia)
illumina presentations
Expression Profiling Using Illumina BeadArray™ Technology
Shawn Baker, Ph.D.
Introduction to Illumina's VeraCode™ Technology: Advancing Molecular
Testing to the 21st Century
Elliott Gorfain, Illumina
DNA Analysis Solutions from Illumina
Dan Peiffer, Ph.D., Illumina
customer presentations
Genetics of Complex Pediatric Disorders: The Experience from Genome-Wide
Association Studies at CHOP
Hakon Hakonarson, Ph.D., Children's Hospital of Philadelphia
Analysis of Transcript Profiles from Whole Blood and Formalin-Fixed,
Paraffin-Embedded Tissue Specimens
Wendell Jones, Ph.D., Expression Analysis
From Infinium to VeraCode: A Perfect Genotyping Match
Annette Lee, Ph.D., The Robert S. Boas Center for Genomics and Human Genetics,
The Feinstein Institute for Medical Research,
North Shore Long Island Jewish Health System
Genome Re-Sequencing and Variant Detection Using the Illumina
Genome Analyzer
Elaine R. Mardis, Ph.D., Washington University School of Medicine
A Genome-Wide Association Study of Major Determinants for Host
Control of HIV-1
Kevin Shianna, Ph.D., Duke IGSP
April-May 2007 (London, Paris, & Munich)
customer presentations
Implementation of the Illumina 1G Solexa platform at the Wellcome Trust
Sanger Institute
Chris Clee, The Wellcome Trust Sanger Institute
Micro-Array Genome Wide Scan Identifies Novel Risk Loci for Type 2 Diabetes
Christian Dina, Pasteur Institute
Gene Expression Profiling During Cerebellum Development in a Down Syndrome
Mouse Model
Julien Laffaire, Ph.D., ESPCI
Detection of Epigenomic Changes in Malignant Lymphomas and Imprinting
Disorders
Jose Ignacio Martin-Subero, Ph.D., University Hospital Kiel
|
overview
what is a snp?
